PanCAN’s COVID-19 Grants Policy Statement
We are aware of and monitoring the challenges resulting from COVID-19 and its management strategies on the advancement of cancer research. In order to mitigate some of the long-term impact on pancreatic cancer research, we will be providing as much flexibility as we can to our grantees at this time. Requests will be evaluated on a case-by-case basis in order to optimize benefit to pancreatic cancer patients. We are committed to ongoing improvement in patient care in years ahead while keeping our community safe. For any questions or concerns, please contact us at email@example.com.
By offering grants for basic, translational and clinical research in pancreatic cancer to scientists and clinicians at various career levels, the Pancreatic Cancer Action Network accelerates progress in the fight against the disease by advancing research toward the goal of improving patient outcomes.
Since 2003, we have awarded 199 grants to 187 scientists at 71 institutions and our total projected research investment is approximately $126 million to date, including our competitive Research Grants Program and leading-edge scientific and clinical initiatives.
Grants AwardedView Funding Opportunities
Evaluation of Research Grants Program
We regularly evaluate our research grants program to assess its effectiveness in building a comprehensive research community and moving the science toward improving patient outcomes. Read more about the impact of the Pancreatic Cancer Action Network research grants program.
Public Access Publication Policy
The Pancreatic Cancer Action Network funds grants for biomedical research to better understand the causes of pancreatic cancer and to advance its prevention, detection, treatment and cure. The main output of this research is new knowledge. To ensure this knowledge can be accessed, read, applied and built upon in fulfillment of our goals, the Pancreatic Cancer Action Network expects its researchers to publish their findings in peer-reviewed journals.